163 related articles for article (PubMed ID: 36367353)
1. Prognostic value of procalcitonin in cancer patients with coronavirus disease 2019.
Tiutan T; Wallins JS; Brown S; Gonen M; Korenstein D
Clin Chem Lab Med; 2023 Jan; 61(2):339-348. PubMed ID: 36367353
[TBL] [Abstract][Full Text] [Related]
2. Association of procalcitonin levels with the progression and prognosis of hospitalized patients with COVID-19.
Liu ZM; Li JP; Wang SP; Chen DY; Zeng W; Chen SC; Huang YH; Huang JL; Long W; Li M; Gao RF; Guo L; Wu XH
Int J Med Sci; 2020; 17(16):2468-2476. PubMed ID: 33029089
[No Abstract] [Full Text] [Related]
3. High procalcitonin levels associated with increased intensive care unit admission and mortality in patients with a COVID-19 infection in the emergency department.
Tong-Minh K; van der Does Y; Engelen S; de Jong E; Ramakers C; Gommers D; van Gorp E; Endeman H
BMC Infect Dis; 2022 Feb; 22(1):165. PubMed ID: 35189826
[TBL] [Abstract][Full Text] [Related]
4. The role of procalcitonin in predicting risk of mechanical ventilation and mortality among moderate to severe COVID-19 patients.
Twe CW; Khoo DKY; Law KB; Ahmad Nordin NSB; Sathasivan S; Lim KC; Atikah SK; Syed Badaruddin SNAB; Chidambaram SK
BMC Infect Dis; 2022 Apr; 22(1):378. PubMed ID: 35428273
[TBL] [Abstract][Full Text] [Related]
5. Searching for a role of procalcitonin determination in COVID-19: a study on a selected cohort of hospitalized patients.
Dolci A; Robbiano C; Aloisio E; Chibireva M; Serafini L; Falvella FS; Pasqualetti S; Panteghini M
Clin Chem Lab Med; 2020 Nov; 59(2):433-440. PubMed ID: 33554505
[TBL] [Abstract][Full Text] [Related]
6. Effects of procalcitonin on antimicrobial treatment decisions in patients with coronavirus disease 2019 (COVID-19).
Conlon ASC; Chopra Z; Cahalan S; Cinti S; Rao K
Infect Control Hosp Epidemiol; 2023 Aug; 44(8):1314-1320. PubMed ID: 36330692
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Utility of Procalcitonin, Presepsin, and the VACO Index for Predicting 30-day Mortality in Hospitalized COVID-19 Patients.
Park M; Hur M; Kim H; Lee CH; Lee JH; Kim HW; Nam M
Ann Lab Med; 2022 Jul; 42(4):406-414. PubMed ID: 35177561
[TBL] [Abstract][Full Text] [Related]
8. Procalcitonin levels in COVID-19 patients.
Hu R; Han C; Pei S; Yin M; Chen X
Int J Antimicrob Agents; 2020 Aug; 56(2):106051. PubMed ID: 32534186
[TBL] [Abstract][Full Text] [Related]
9. Baseline procalcitonin as a predictor of bacterial infection and clinical outcomes in COVID-19: A case-control study.
Atallah NJ; Warren HM; Roberts MB; Elshaboury RH; Bidell MR; Gandhi RG; Adamsick M; Ibrahim MK; Sood R; Bou Zein Eddine S; Cobler-Lichter MJ; Alexander NJ; Timmer KD; Atallah CJ; Viens AL; Panossian VS; Scherer AK; Proctor T; Smartt S; Letourneau AR; Paras ML; Johannes S; Wiemer J; Mansour MK
PLoS One; 2022; 17(1):e0262342. PubMed ID: 35025929
[TBL] [Abstract][Full Text] [Related]
10. Procalcitonin as a predictor of severity and mortality in a cohort of patients hospitalised with COVID-19.
Ahmed S; Ahmed ZA; Rashid NH; Mansoor M; Siddiqui I; Jafri L
Malays J Pathol; 2021 Dec; 43(3):375-380. PubMed ID: 34958058
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic stewardship: Early discontinuation of antibiotics based on procalcitonin level in COVID-19 pneumonia.
Roy A; Powers HR; Craver EC; Nazareno MD; Yarrarapu SNS; Sanghavi DK
J Clin Pharm Ther; 2022 Feb; 47(2):243-247. PubMed ID: 34766357
[TBL] [Abstract][Full Text] [Related]
12. Procalcitonin and secondary bacterial infections in COVID-19: association with disease severity and outcomes.
Vazzana N; Dipaola F; Ognibene S
Acta Clin Belg; 2022 Apr; 77(2):268-272. PubMed ID: 32966166
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Procalcitonin's Utility to Predict Concomitant Bacterial Pneumonia in Critically Ill COVID-19 Patients.
Patel N; Adams C; Brunetti L; Bargoud C; Teichman AL; Choron RL
J Intensive Care Med; 2022 Nov; 37(11):1486-1492. PubMed ID: 35711161
[No Abstract] [Full Text] [Related]
14. The Level of Procalcitonin in Severe COVID-19 Patients: A Systematic Review and Meta-Analysis.
Heidari-Beni F; Vahedian-Azimi A; Shojaei S; Rahimi-Bashar F; Shahriary A; Johnston TP; Sahebkar A
Adv Exp Med Biol; 2021; 1321():277-286. PubMed ID: 33656733
[TBL] [Abstract][Full Text] [Related]
15. A risk score based on procalcitonin for predicting acute kidney injury in COVID-19 patients.
Wang RR; He M; Kang Y
J Clin Lab Anal; 2021 Jun; 35(6):e23805. PubMed ID: 34032326
[TBL] [Abstract][Full Text] [Related]
16. Serum procalcitonin level is independently associated with mechanical ventilation and case-fatality in hospitalized COVID-19-positive US veterans-A potential marker for disease severity.
Jeyapalina S; Wei G; Stoddard GJ; Sudduth JD; Lundquist M; Huntsman M; Marquez JL; Agarwal JP
PLoS One; 2023; 18(4):e0284520. PubMed ID: 37068086
[TBL] [Abstract][Full Text] [Related]
17. Procalcitonin as a Prognostic Factor in Patients with COVID-19 in Southwestern Iran.
Abadi MSS; Taheri E; Raesi A; Arjmand MH; Kheirii S; Shahinfard N; Habibi Z
Infect Disord Drug Targets; 2022; 22(3):e070122200097. PubMed ID: 34994319
[TBL] [Abstract][Full Text] [Related]
18. C-reactive protein and procalcitonin for antimicrobial stewardship in COVID-19.
Pink I; Raupach D; Fuge J; Vonberg RP; Hoeper MM; Welte T; Rademacher J
Infection; 2021 Oct; 49(5):935-943. PubMed ID: 34021897
[TBL] [Abstract][Full Text] [Related]
19. Low Vitamin D Status at Admission as a Risk Factor for Poor Survival in Hospitalized Patients With COVID-19: An Italian Retrospective Study.
Infante M; Buoso A; Pieri M; Lupisella S; Nuccetelli M; Bernardini S; Fabbri A; Iannetta M; Andreoni M; Colizzi V; Morello M
J Am Nutr Assoc; 2022; 41(3):250-265. PubMed ID: 33600292
[TBL] [Abstract][Full Text] [Related]
20. Clinical, radiological, and laboratory characteristics and risk factors for severity and mortality of 289 hospitalized COVID-19 patients.
Zhang JJ; Cao YY; Tan G; Dong X; Wang BC; Lin J; Yan YQ; Liu GH; Akdis M; Akdis CA; Gao YD
Allergy; 2021 Feb; 76(2):533-550. PubMed ID: 32662525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]